MRO Asia-Pacific is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

October 9-11, 2019

Hilton Chicago

Conference: October 9-11, 2019
Exhibit Hall: October 10-11, 2019

Ronald T Ackermann, MD, MPH, FACP

Senior Associate Dean for Public Health; Director, Institute for Public Health and Medicine; Director, Center of Diabetes and Metabolism
Northwestern University


Profile

Ronald T. Ackermann, MD, MPH is Senior Associate Dean for Public Health and Professor of Medicine at Northwestern University Feinberg School of Medicine in Chicago. He directs Northwestern University’s Institute for Public Health and Medicine and is Co-Director for the Center for Diabetes and Metabolism. He is a health researcher and practicing primary care clinician who is considered an international expert in the design and evaluation of policies, systems, and programs to prevent and manage type 2 diabetes and other cardiovascular risk conditions. Since 2004, he has been continuously funded as the principal investigator of federal research grants that have helped inform nationwide implementation of community and health system-based interventions to prevent type 2 diabetes, as well as health payer reimbursements for those services. From 2013-2015 he chaired an expert panel of the National Diabetes Education Program to develop new resources and tools to assist practicing healthcare providers in the prevention of type 2 diabetes. He also currently serves as Co-Chair of the American Medical Association’s Prediabetes Quality Measures Technical Expert Panel, and he is funded by the NIH under federal award R18DK110741 to evaluate the impact of national and regional policies and large-scale health system initiatives aiming to increase rates of prediabetes and diabetes screening, as well as the delivery of interventions to prevent type 2 diabetes among U.S. adults.

Sessions